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ORIGINAL RESEARCH COMMUNICATION
Analysis of the Bacterial Response to Ru(CO)3Cl(Glycinate)
(CORM-3) and the Inactivated Compound Identifies
the Role Played by the Ruthenium Compound
and Reveals Sulfur-Containing Species
as a Major Target of CORM-3 Action
Samantha McLean,1 Ronald Begg,2 Helen E. Jesse,1 Brian E. Mann,3
Guido Sanguinetti,2 and Robert K. Poole1
Abstract
Aims: Carbon monoxide (CO)-releasing molecules (CO-RMs) are being developed with the ultimate goal of
safely utilizing the therapeutic potential of CO clinically. One such application is antimicrobial activity; therefore,
we aimed to characterize and compare the effects of the CO-RM, CORM-3, and its inactivated counterpart, where
all labile CO has been removed, at the transcriptomic and cellular level. Results:We found that both compounds
are able to penetrate the cell, but the inactive form is not inhibitory to bacterial growth under conditions where
CORM-3 is. Transcriptomic analyses revealed that the bacterial response to inactivated CORM-3 (iCORM-3) is
much lower than to the active compound and that a wide range of processes appear to be affected by CORM-3
and to a lesser extent iCORM-3, including energy metabolism, membrane transport, motility, and the metabolism
of many sulfur-containing species, including cysteine and methionine. Innovation: This work has demonstrated
that both CORM-3 and its inactivated counterpart react with cellular functions to yield a complex response at the
transcriptomic level. A full understanding of the actions of both compounds is vital to understand the toxic
effects of CO-RMs. Conclusion: This work has furthered our understanding of how CORM-3 behaves at the
cellular level and identifies the responses that occur when the host is exposed to the Ru compound as well as
those that result from the released CO. This is a vital step in laying the groundwork for future development of
optimized CO-RMs for eventual use in antimicrobial therapy. Antioxid. Redox Signal. 19, 1999–2012.
Introduction
Carbon monoxide (CO) acts as a respiratory inhibitor bybinding to heme groups and preventing electron transfer
to O2 (23). CO is also generated within the human body via the
breakdown of heme by the enzyme heme oxygenase. The CO
generated endogenously fulfills a variety of roles, with prop-
erties as diverse as signaling and bactericidal activity (6,9).
However, utilizing CO gas as a therapeutic tool has proven
difficult due to its toxic properties and the systemic delivery
methods used for administration (5). CO-releasing molecules
(CO-RMs) have been developed for over 10 years in an at-
tempt to harness the beneficial properties of CO while mini-
mizing its toxic effects. These CO-RMs have been synthesized
with a variety of functions in mind, including targeting and
specificity. There is now a wide variety of carbonyl com-
pounds with centers that include ruthenium, iron, manga-
nese, and boron (26,27). Their CO-release rates and kinetics
are also diverse with half-lives of seconds to hours. CO-RMs
liberate CO in a variety of conditions, including by dissocia-
tion in biological buffers (13), by photodissociation (38) and
via enzyme activity (33).
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Ru(CO)3Cl(glycinate),more commonly known as CORM-3,
is a water-soluble Ru-containing compound, capable of
releasing one CO per molecule with a half-life of *2min
in vitro (8,28). CORM-3 is bactericidal against a variety of
microbes, including Escherichia coli, Pseudomonas aeruginosa,
and Staphylococcus aureus (10,12,13,30,40).
To assess which of the observed effects upon exposure to
CORM-3 are a result of CO and which are caused by the Ru-
compound devoid of labile CO, it is important to utilize the
inactivated compound, iCORM-3, as a control compound.
However a number of studies do not utilize an inactivated
compound as a control (12,13,30) or use control compounds
that are not the inactivated counterpart, but a similar com-
pound where CO has been substituted for another mole-
cule, for example, RuCl2(DMSO)4 (10). In this study, we
made iCORM-3 by incubating fresh CORM-3 dissolved in
phosphate-buffered saline (PBS) at room temperature for up
to 48 h with periodic N2 gas bubbling, after which time very
little CO release can be detected (< 5% than of the same
concentration of CORM-3). This process is thought to allow
CORM-3 to release the labile CO, which escapes into the
gas phase upon bubbling, leaving a CO-depleted iCORM-3
compound in solution (8). However, mounting literature
suggests that CORM-3 is unable to release large quantities of
CO under these conditions; rather, the carbonyl compound is
altered forming a stable molecule that releases CO with a
much slower rate (13,28,37). This inactivation process could
produce a very slow CO-releasing tricarbonyl complex (22) or
a dicarbonyl compound, which is formed via the release of
CO2 from CORM-3 (37). Whichever form is made, we can be
sure that this inactivated compound is made directly from the
active CORM-3 molecule and is therefore likely to mimic the
compound present in vivo after CO has been released.
Despite the ambiguity of its chemical structure, the
iCORM-3 compound has been used in studies as a non-CO
releasing control for CORM-3 (8,17,34,37) to test the reactivity
of the Ru-compoundwhen all labile CO has been removed. In
all cases, iCORM-3 was shown to be much less reactive than
the CO-RM.
However, no work has been carried out to directly
characterize and compare in detail the observed effects of
iCORM-3 and CORM-3 on bacteria. This comparison is es-
sential to further our understanding of how these molecules
behave at the cellular level and is a vital step in laying the
groundwork for future development of optimized CO-RMs
for eventual use in antimicrobial therapy.
Results
Growth of E. coli after treatment with CORM-3
or iCORM-3 and intracellular uptake of Ru
To establish a concentration of CORM-3 that was mildly
inhibitory, but not bactericidal, in the Evans growth medium,
cells were grown in batch culture to an OD600 *0.4, when
CORM-3 or iCORM-3 was added to a final concentration of
40 lM. After addition of 40 lM CORM-3, a slight transient
reduction in the growth rate was seen (Fig. 1A); this was
sufficient to challenge bacterial cells without a significant
loss in viability. Addition of 40lM iCORM-3 resulted in no
perturbation of growth.
FIG. 1. Growth of Escherichia coli in Evans medium
treated with Ru(CO)3Cl(glycinate) (CORM-3), inactivated
CORM-3 (iCORM-3), or CO-saturated solution and intra-
cellular uptake of the Ru compound. Cells were grown in
batch culture to a turbidity of 40 Klett units and treated with
40 lM CORM-3 (closed circles), iCORM-3 (open circles), or
CO-saturated solution (open triangles). (A) Growth was
monitored every 30min. N ‡ 2– standard error of the mean
(SEM). (B) Samples were taken at 0, 2.5, 5, 10, 20, 40, and
80min post-treatment, and cell pellets were analyzed by in-
ductively coupled plasma mass spectrometry for Ru content.
N ‡ 3 – SEM. Dotted horizontal line represents an extracellu-
lar concentration of iCORM-3 (40 lM).
Innovation
Carbon monoxide-releasing molecules (CO-RMs) de-
liver carbon monoxide (CO) to cells and tissues and show
promising results as antimicrobial agents. However, ratio-
nal exploitation of CO-RMs requires fundamental under-
standing of their activity, and appreciation of the biological
impacts of the CO-RM residue after CO has been liberated.
We report that CORM-3 and its CO-depleted form have
comprehensive time-dependent effects on the transcript
profiles in Escherichia coli particularly in the genes impli-
cated in energy and sulfur metabolism, although the effects
of CORM-3 are more profound than those of the inactive
residue. Our work highlights the need for integration of
chemistry, physiology, and molecular biology before CO-
RMs are used clinically.
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Previous work showed that CORM-3 is able to enter
growing E. coli cells (10), but this assay was performed at only
one time point. To expand upon this, we used inductively
coupled plasmamass spectrometry to determine the level and
rate of uptake of CORM-3 or iCORM-3 viameasurement of the
intracellular Ru content of cells over time. This method was
chosen for detection of the CORM-3 and iCORM-3, as Ru is
absent from untreated cells. CORM-3was rapidly taken up by
the cell as intracellular Ru accumulated at a rate in excess of
85 lM$min - 1 over the first 2.5min after treatment. Cellular
Ru levels reached a plateau at *40min (Fig. 1B), indicating
that import of the compound had stopped or that an equi-
librium was reached between import and export. Analysis of
samples exposed to iCORM-3 showed that the concentration
of this compound accumulated in cells with an initial rate
of *40lM$min - 1 and to approximately half the final con-
centration of CORM-3 (Fig. 1B).
Whole-genome analysis shows distinct responses
of E. coli treated with CORM-3 or iCORM-3
To assess how bacterial cells perceive and react to CORM-3
and iCORM-3 over time, transcriptomic analyses of continu-
ously growing cultures were performed after exposure to a
final concentration of 40lM CORM-3 or iCORM-3 at 0 and
100% perceived aerobiosis (2). This is ameasure of the extent of
O2 deprivation, judged not by residual O2 levels in the che-
mostat, but by assaying the formation of acetate, a fermentation
product that is produced when cells can no longer respire
aerobically. Samples were taken immediately before addition
of the CO-RM and 2.5, 5, 10, 20, 40, and 80min after, to gain an
understanding of the initial responses and subsequent effects.
Under aerobic conditions, addition of CORM-3 caused
changes in gene expression across a wide variety of functional
groups with up to 23% of the entire genome being signifi-
cantly altered (< 0.5-fold or > 2-fold change in expression)
40min after exposure (Fig. 2). Changes in gene expression
rose rapidly in the first 10min, followed by a more gradual
increase up to 80min. In contrast, upon exposure to iCORM-3,
there was a much smaller response with a peak of only*2%
of the entire genome being altered at 10min, followed by a
decline in activity to virtually zero by 40min (Fig. 3).
In response to both compounds, many genes involved in
energy metabolism, amino acid metabolism, and ABC trans-
port were altered. However CORM-3 had much more broad-
ranging effects, including alteration of genes involved in cell
motility, signal transduction, and carbohydrate metabolism
(Fig. 2).
Under anaerobic conditions, there were also changes in
genes from a wide variety of functional groups after exposure
to CORM-3 (*24% of the entire genome by 80min; Supple-
mentary Fig. S1; Supplementary Data are available online at
www.liebertpub.com/ars). There were many more genes
upregulated under these conditions in contrast to aerobically
grown cultures, where the general trendwas downregulation.
When challenged with iCORM-3 under anaerobiosis, there
was also a broad response, but only*6% of the genome was
significantly altered at its peak (20min; Supplementary Fig.
S2). Genes belonging to broadly the same functional groups
were altered by iCORM-3, both aerobically and anaerobically.
Although the genes altered were from a wide range of
functional groups under all conditions, the magnitude of
these changeswasmarkedly different between the conditions.
CORM-3 under both the aerobic and anaerobic conditions
caused much greater alterations in expression of the genes
than iCORM-3 (Fig. 4). Full details of all transcriptomic data
can be found in the Gene Expression Omnibus database (ac-
cession: GSE40811).
Differential effects of CORM-3 and iCORM-3 under
aerobic and anaerobic growth conditions
Gene expression timeseries, generated from microarray
analysis, were used to infer transcription factor (TF) activities
FIG. 2. Expression changes of genes belonging to functional groups in response to CORM-3 exposure under aerobic
conditions. Wild-type E. coli cells were grown aerobically in a continuous culture and a defined minimal medium before
addition of 40lM CORM-3. Samples were taken at 0, 2.5, 5, 10, 20, 40, and 80min after addition of the compound and
analyzed transcriptomically. The bars show the percentage of genes belonging to each group that were altered at each time
point. Black bars indicate upregulation, and gray bars indicate downregulation.
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using the TFInfer statistical software suite (3). Given micro-
array data from E. coli grown under aerobic or anaerobic
conditions and either in the presence or in the absence of
CORM-3 or iCORM-3, TFInfer returns the probability distri-
butions for the activity of each TF, as well as the strengths of
the TF–target interactions (see the Materials and Methods
section).
Here, we are interested in probing the way in which TFs
respond to different stimuli. We tested two complementary
aspects: which TFs have a similar dynamical response to
FIG. 4. The patterns of
E. coli gene expression after
exposure to CORM-3 or
iCORM-3 are distinct. The
whole-genome expression pro-
files of E. coli cultures treated
with 40lM CORM-3 (A, C) or
iCORM-3 (B, D) are shown
over a time course of 2.5, 5, 10,
20, 40, and 80min. Each line
represents a single gene, and
those upregulated after 20min
are shown in red; down-
regulated genes at this time are
shown in blue; and genes that
do not significantly alter in
expression level at 20min are
shown in yellow.
FIG. 3. Expression changes of genes belonging to functional groups in response to iCORM-3 exposure under aerobic
conditions. Wild-type E. coli cells were grown aerobically in a continuous culture and a defined minimal medium before
addition of 40 lM iCORM-3. Samples were taken at 0, 2.5, 5, 10, 20, 40, and 80min after addition of the compound and
analyzed transcriptomically. The bars show the percentage of genes belonging to each group that were altered at each time
point. Black bars indicate upregulation, and gray bars indicate downregulation.
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different stimuli, and which TFs have a significantly different
response to different stimuli. To answer the first question,
absolute Pearson correlation coefficients were used to com-
pare TF activities in different conditions. Using the probabi-
listic nature of TFInfer software, we are able to compute a
distribution for the (absolute) correlation coefficient between
the TF response to CORM-3 and iCORM-3 in aerobic and
anaerobic conditions (see Supplementary Data for why the
absolute value was used). The TFs were ranked according to
their mean absolute correlation coefficient, where a low
number indicates that the TF responses had a low correlation
between the two conditions, and a number approaching 1
indicates high correlation.
The Pearson correlation comparison results are shown in
Table 1 for aerobic growth conditions and Table 2 for anaer-
obic growth conditions. In Table 1, for example, the activity of
ArcA, which represses respiratory metabolism, is uncorre-
lated upon exposure to CORM-3 and iCORM-3 under aerobic
conditions. Further examination reveals that the activity of
this TF is increased upon exposure to CORM-3, but to a much
lesser extent upon exposure to iCORM-3 (Supplementary
Tables 1–4). Anaerobically, however, the response of ArcA to
CORM-3 and iCORM-3 shows a much greater correlation
(Table 2). In the case of IscR, which is involved in the regu-
lation of the iron–sulfur cluster assembly, there is a similar
pattern of behavior when challenged with either CORM-3 or
iCORM-3 both aerobically and anaerobically, suggesting that
damage to the iron–sulfur clusters could be a consequence of
exposure to the CORM-3/iCORM-3 Ru-based compound
(Tables 1 and 2).
Table 1. Absolute Pearson Correlations Comparing
Cells Treated with CORM-3 or iCORM-3
Under Aerobic Conditions
Transcription
factor name
Mean absolute
Pearson correlation
Standard deviation
of correlation
CRP 0.079 0.059
ArcA 0.125 0.091
IHF 0.195 0.072
FlhDC 0.197 0.134
CusR 0.212 0.139
OmpR 0.226 0.164
HNS 0.276 0.151
EvgA 0.281 0.165
MarA 0.299 0.206
FruR 0.338 0.213
PdhR 0.341 0.227
MhpR 0.342 0.228
YdeO 0.343 0.228
GalR 0.344 0.230
Lrp 0.345 0.110
RstA 0.352 0.230
MalT 0.352 0.207
GlcC 0.355 0.232
IclR 0.358 0.234
NarP 0.368 0.237
Nac 0.384 0.246
GadE 0.401 0.249
GalS 0.422 0.252
DgsA 0.439 0.246
Fur 0.506 0.213
AraC 0.555 0.229
NarL 0.601 0.226
ModE 0.631 0.215
GadWX 0.723 0.156
IscR 0.734 0.126
PhoP 0.745 0.168
GcvA 0.790 0.036
NtrC 0.814 0.093
Fis 0.823 0.097
FNR 0.867 0.071
CpxR 0.946 0.030
Transcription factors (TFs) are ranked by their mean absolute
Pearson correlation obtained by sampling the TF profiles from the
posterior distribution obtained through the inference procedure
described in the Materials and Methods section. Listed also is the
resulting standard deviation of the absolute Pearson correlation.
CORM-3, Ru(CO)3Cl(glycinate); iCORM-3, inactivated CORM-3.
Table 2. Absolute Pearson Correlations Comparing
Cells Treated with CORM-3 or iCORM-3
Under Anaerobic Conditions
Transcription
factor name
Mean absolute
Pearson correlation
Standard deviation
of correlation
NtrC 0.158 0.085
PdhR 0.179 0.128
Nac 0.186 0.139
DgsA 0.239 0.168
CusR 0.249 0.179
Fur 0.305 0.197
NarP 0.327 0.222
AraC 0.344 0.228
YdeO 0.344 0.227
GalR 0.345 0.230
MhpR 0.345 0.228
Lrp 0.346 0.112
IclR 0.348 0.228
ModE 0.352 0.229
FlhDC 0.376 0.160
FruR 0.380 0.138
EvgA 0.380 0.128
GlcC 0.417 0.247
NarL 0.556 0.194
CRP 0.592 0.031
MalT 0.628 0.127
GalS 0.659 0.202
MarA 0.675 0.212
Fis 0.697 0.077
ArcA 0.735 0.056
OmpR 0.758 0.146
CpxR 0.791 0.026
GadE 0.820 0.126
IHF 0.822 0.048
GcvA 0.865 0.062
HNS 0.867 0.043
GadWX 0.874 0.048
RstA 0.886 0.059
IscR 0.897 0.042
FNR 0.902 0.059
PhoP 0.953 0.024
TFs are ranked by their mean absolute Pearson correlation
obtained by sampling TF profiles from the posterior distribution
obtained through the inference procedure described in the Materials
and Methods section. Listed also is the resulting standard deviation
of the absolute Pearson correlation.
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To assess significantly different TF responses across con-
ditions, a modification of the TFInfer algorithm was needed.
Briefly, we combined the data from two conditions (e.g.,
CORM-3 exposure vs. iCORM-3 exposure) to simultaneously
infer TF activity in both conditions under the (null) hypothesis
that the activity of a given single TF is identical in both con-
ditions. By checking how the model fits the gene expression
profiles of the targets of the given TF, we obtain a p-value for
any given TF being differentially active under the two dif-
ferent conditions. In this way, we can determine whether the
activity of a given TF is significantly different under each
condition tested (in this case, CORM-3 vs. iCORM-3) (see the
Materials and Methods section and Supplementary Data for
more details).
Figure 5 shows the TFs identified as being differentially
affected ( p< 0.05) by exposure to CORM-3 versus iCORM-3
under both the aerobic and anaerobic growth conditions. It
can be seen that there are 6 TFs identified as being differen-
tially affected under aerobic conditions only and 13 identified
as being differentially affected under both conditions, and
that the TFs differentially affected anaerobically are a subset
of those affected aerobically.
Interestingly, IscR was differentially affected by CORM-3
and iCORM-3 under aerobic conditions in this test. As the
activity of this TF was found to correlate under these condi-
tions (Table 1), this suggests that while the response of IscR
correlates after exposure to either molecule, that is, its pattern
of activity is similar (Tables 1 and 2), the magnitude of that
response may differ making the activities significantly dif-
ferent here (Fig. 5C). Another similar example is that of ArcA,
mentioned above, which has much higher correlation in an-
aerobic conditions, but is still identified as having signifi-
cantly different activity under exposure to CORM-3 or
iCORM-3.
Carbohydrate and intermediary energy metabolism
is altered in response to CORM-3
In the presence of CORM-3, there was a general trend of
downregulation in carbohydrate metabolism and transport
genes from *10min post-treatment (Fig. 2). Accompanying
this trend was a downregulation of the genes involved in
energy metabolism. Many genes involved in oxidative phos-
phorylation, the reductive carboxylate cycle, and ubiquinone
biosynthesis were downregulated (Supplementary Figs. S1,
S3, and S4). The formate dehydrogenase-O genes, which
rapidly increase in the expression levels in response to a
switch from aerobic to anaerobic conditions, were also
downregulated under these conditions (1). This indicates that
the presence of CORM-3 does not simply cause the cell to shift
to an anaerobic form of energy metabolism to bypass the
quinol oxidases, known to be inhibited by CO (23). Upon
exposure to iCORM-3, carbohydrate transport and metabo-
lism and energy metabolism were largely unaffected (Fig. 3
and Supplementary Figs. S2–S4). Real time PCR (RT-PCR)
confirmed that the expression of cyoD, the gene encoding the
cytochrome bo terminal oxidase subunit IV, was also down-
regulated in response to treatment of growing cultures with
CO gas at a rate of 50ml$min - 1 (Supplementary Fig. S5),
confirming the role of CO-RM-derived CO and CO gas per se
in targeting energy metabolism.
ABC transporter expression is altered
in response to CORM-3
Transport also appears to be a crucial response to CORM-3.
Many ABC transporters were downregulated, including the
dipeptide permease dppABCDF, responsible for transport of
dipeptides into the cell (see GEO: GSE40811). In response to
iCORM-3, the downregulation was much less pronounced
FIG. 5. Differential transcription factor (TF) activity of cells exposed to CORM-3 versus iCORM-3 under aerobic or
anaerobic conditions. (A) TFs identified as having a significantly different activity ( p < 0.05) after exposure to CORM-3 or
iCORM-3. The outer rings of TFs are those that are identified as differentially active under aerobic growth conditions only.
The inner circle contains those TFs identified as differentially active under both aerobic and anaerobic conditions. (B) The
remaining TFs that were not identified as differentially active under either aerobic or anaerobic growth conditions. (C)
Theoretical change in activity of the TF IscR (as generated by TFInfer) in response to CORM-3 (closed circles) and iCORM-3
(open circles) under aerobic (solid lines) or anaerobic (dashed lines) conditions.
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(with a maximum approximately threefold downregulation).
Further, the expression of dppB, in samples exposed to CO gas
(50ml$min-1), was not significantly altered (Supplementary
Fig. S5), suggesting that the response of this transporter is
probably due to theCORM-3 compound. To determinewhether
the dipeptide permease was a mechanism by which CORM-3
enters the cell and thus the reason for its apparent down-
regulation by the bacterium in response to CO-RM, a dppB
knockout strainwas tested.When challengedwithCORM-3,we
found that the dppB mutant was more sensitive to CORM-3
treatment than the wild-type strain (Fig. 6), suggesting that not
onlywas theCORM-3molecule still able to enter the cell but also
a loss in function of the dipeptide permease is disadvantageous
after CORM-3 treatment. Indeed, CORM-3 entry into the dppB
knockout strain was confirmed by Ru analysis after addition of
the compound to a final concentration of 40lM. After 20-min
exposure, 227–19lMRuwas found inside the cells, confirming
that CORM-3 passage into the cell is not significantly affected by
loss of the dipeptide permease transport system.
Several other transporters were upregulated in response to
CORM-3, including the sulfate–thiosulfate transport system
encoded by cysPUWA, the oligopeptide permease encoded by
oppABCDF, the methionine transporter (metQIN), and the
glutathione transporter (gsiABCD) (see GEO: GSE40811).
There was no significant alteration in expression of these
systems upon exposure to iCORM-3, and RT-PCR analysis of
samples exposed to bubbling with CO gas showed no sig-
nificant change in expression of oppB (Supplementary Fig. S5),
perhaps suggesting that greater local concentrations of CO
must be targeted to cells, as is the casewith CORM-3, to elicit a
transcriptomic response in these cases.
Cell motility is impaired upon exposure to CO
Expression of the genes involved in cell motility was di-
minished in response to CORM-3 exposure under aerobic
conditions (Fig. 2). In response to iCORM-3, however, the
expression of these genes was largely unaffected. To deter-
mine whether the decrease in expression after treatment with
CORM-3 resulted in reduced motility, swarming assays were
performed under normal conditions and under an atmo-
sphere of 50% CO, as previously described (31,39). After 48-h
incubation, the mean colony diameters were measured as
9.4 – 0.5mm for colonies grown under normal conditions,
whereas cells grown in a 50% CO atmosphere had a reduced
colony diameter of 6.3 – 0.6mm. The Student’s t-test, which
compares the difference between two means in relation to the
variance in the data, revealed that the difference between
these data sets is highly significant ( p-value < 0.001), which
suggests that aerobic exposure to CO results in a lowered
expression of genes responsible for flagella function and
chemotaxis with a corresponding reduction in cell motility.
Sulfur metabolism is a target of CORM-3
and iCORM-3 activity
Our data show that sulfate transport and utilization, in-
cluding the sulfate–thiosulfate transport system and methio-
nine metabolism and transport (cysPUWA andmetQIN), were
altered upon exposure to CORM-3, and to a lesser extent, to
iCORM-3 (Fig. 7 and Supplementary Fig. S6). Increases in the
sulfate–thiosulfate, cysteine, and methionine transport sys-
tems as well as increases in expression of the cysteine and
methionine biosynthesis genes point to a requirement for
sulfur and its metabolism in the presence of the Ru compound
regardless of the presence or absence of the labile CO. How-
ever, an increase in expression of genes that respond to sulfur
starvation (ssuABCDE and tauABCD) was observed only in
conditions when CORM-3 was administered (Fig. 7 and
Supplementary Fig. S6). The tauABCD regulon, responsible
for utilization of taurine as a sulfur source, whose expression
is regulated by a response to sulfur starvation, is also greatly
increased at later time points (2-fold to 65-fold from 10min).
The significance of this is not understood at this time.
CORM-3 causes a reduction in free thiol levels
To determine whether CORM-3 was altering free thiol
levels in vivo and thus causing the alterations seen in the
transcriptomic data of genes that effect thiol metabolism
within the cell, assays were carried out whereby reduced
glutathione, cysteine, and sodium hydrosulfide were exposed
to increasing concentrations of CORM-3, iCORM-3, or CO-
saturated solution, and the presence of free thiols was mea-
sured by the addition of 5,5¢-dithiobis-(2-nitrobenzoic acid)
(DTNB) (14). CORM-3 appeared to reduce the number of thiols
in solution in all cases (Fig. 8). When iCORM-3 was added in
place ofCORM-3, the decrease in the level of free thiolswas less
pronounced, but still significant, suggesting that it is not only
CO release that causes the decrease in free thiols in theCORM-3
assays. Indeed, there was no significant effect on the concen-
tration of free thiol groups upon exposure to CO alone (Fig. 8).
Previous work has shown that another Ru-based CO-RM,
[Ru(CO)3Cl2]2 [CORM-2, (29)], is able to generate reactive O2
species (41). To determine whether similar species are gener-
ated by CORM-3 and cause the decrease in free thiol levels in
the DTNB assays, we investigated whether CORM-3 and
iCORM-3 were able to produce superoxide. We looked for the
generation of this species from CORM-3 via the addition of
FIG. 6. Mutation of the dipeptide permease transporter
causes greater sensitivity to CORM-3. Cultures of WT and
dppB were grown in the Evans medium to early-exponential
phase before washing and dilution in PBS to *106 colony
forming units (CFU)$ml- 1. Cells were exposed to 0.5lM
CORM-3 and incubated for a further hour before plating serial
dilutions to determine the viability as a percentage survival
compared to no-CORM-3 treatment. N= 3– SEM, * denotes p-
value<0.01 as determined by the Student’s t-test. CFU, colony
forming units.
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cytochrome c to a solution of CORM-3 in buffer. This assay
uses the reduction of cytochrome c by superoxide, which can
be measured spectrophotometrically (42). Figure 8D shows a
reduction of cytochrome c in the presence of CORM-3, a re-
action that is almost entirely abolished by the addition of
superoxide dismutase. The addition of iCORM-3 to cyto-
chrome c appears to enhance formation of the reduced spe-
cies, suggesting that more superoxide is generated by
iCORM-3 than CORM-3. However, the superoxide generated
by these compounds is very small, only*1% of the CORM-3
or iCORM-3 concentration; therefore, the impact this would
have on the DTNB assay is negligible.
While CO seems to play no direct role in reduction of free
thiol levels, the Ru compound does seem to cause a loss of free
FIG. 7. Differential ex-
pression of genes involved
in sulfate transport and me-
tabolism. The color-scale bar
shows the mean fold changes
in individual genes of E. coli
grown aerobically in the
Evans medium after the ad-
dition of 40 lM CORM-3 or
iCORM-3.
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thiols available to the DTNB (Fig. 8). It is likely that the thiols
bind to Ru, possibly displacing a chloride ion on the CORM-3
and iCORM-3 compounds.
Thiol-containing compounds prevent
CORM-3-dependent inhibition of respiration
in E. coli membrane particles
Another possible reason for the alteration in expression of
thiol-containing compounds is that they may afford pro-
tection to the cell via interaction with CORM-3. One striking
target of CORM-3 is respiration via CO binding to the
terminal quinol oxidases (10). To assess whether thiol-
containing compounds were able to reduce the inhibition of
respiration caused by CORM-3, the respiration of the E. coli
membrane particles was monitored by measuring O2 con-
sumption in a closed electrode system (18). Inhibition
of respiration was observed after the addition of 400lM
CORM-3 to the membrane suspensions; this effect was
abolished upon addition of reduced glutathione (200lM) or
cysteine (400lM) (Fig. 9), which suggests that increasing
thiol concentrations may be an effective protective mecha-
nism for cellular respiration.
FIG. 8. CORM-3 has a biphasic effect on the presence of free thiols from glutathione, sulfide, and cysteine. CORM-3 (0–
400 lM) (closed circles), iCORM-3 (open circles), or CO-saturated solution (closed triangles) was mixed with 100lM (A)
cysteine, (B) reduced glutathione, or (C) sodium hydrosulfide and incubated for 15min at room temperature; 500lM 5,5¢-
dithiobis-(2-nitrobenzoic acid) was added, and the solution incubated for a further 15min before the absorbance was mea-
sured at 412 nm. N = 3– SEM. (D) Cytochrome c (20lM) was added to CORM-3 (1mM, open symbols) or iCORM-3 (1mM,
closed symbols) in the presence (triangles) or absence (circles) of superoxide dismutase (250U) in KPi (pH 7.4). The OD550 was
measured over time as a measure of the reduction of cytochrome c. N = 3, standard errors were £ 1 lM.
FIG. 9. Thiol-containing compounds prevent CORM-3-
dependent inhibition of respiration in E. coli membrane
particles. E. coli membrane particles were added to the
sonication buffer to a final concentration of *60lg$ml- 1
inside the O2 electrode chamber. A lid was placed on the
chamber, and respiration was initiated by the addition of
6.25mM nicotinamide adenine dinucleotide. Arrows indicate
the addition of (A) 200lM reduced glutathione or (B) 400 lM
cysteine and the addition of 400lM CORM-3 as described.
The dashed lines indicate uninhibited respiration; the solid
lines show O2 consumption in the presence of CORM-3, and
the dotted lines show O2 consumption in the presence of
CORM-3 and the thiol-containing compound. Figure is rep-
resentative of three biological repeats for each condition.
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Discussion
Although previous work has shown that iCORM-3 has
much less effect than CORM-3 on biological material
(8,17,34,37), very little has been done to elucidate bacterial
viability with, and specific responses to, iCORM-3. The data
presented herein show that iCORM-3 (made via incubation
of CORM-3 in PBS) has virtually no effect on the growth of
E. coli, whereas at the same concentration, CORM-3 readily
inhibits growth (Fig. 1A). We have shown that iCORM-3 is
able to rapidly enter bacterial cells, but only accumulates to
half the concentration as CORM-3 (Fig. 1B), indicating that
the lack of bactericidal activity afforded by iCORM-3 can
only be partially attributed to a decrease in cellular pene-
tration. Further, our transcriptomic and modeling data re-
veal for the first time that there is a much greater response
to CORM-3 than to iCORM-3 over the whole genome, with
up to 24% of the genome being altered in response to
CORM-3 and as little as 2% altered by the Ru compound
devoid of labile CO (Figs. 2 and 3; Supplementary Figs. S1
and S2). This suggests that the majority of changes seen in
transcriptomic experiments in the presence of CORM-3 are
due to the release of free CO. One notable exception is the
gene spy, whose expression is upregulated as much as
*565-fold upon exposure to CORM-3, but only *4.6-fold
upon exposure to the same concentration of iCORM-3, and
is not significantly altered after continued exposure to CO
gas at a rate of 50ml$min - 1. This suggests that exposure to
the intact CORM-3 compound is somehow responsible for
the changes seen.
Further analysis was undertaken via determination of TF
activities under all conditions using probabilistic modeling
tools. In Figure 5, one explanation for why the outer ring
of TFs is differentially affected by CORM-3 versus iCORM-3
in aerobic growth conditions, but not anaerobic growth
conditions, is that the TFs are responding to simulated
anaerobic conditions induced by CO from CORM-3. If
the cells are already growing under anaerobic conditions,
this effect will not be manifested, so these TFs are not
differentially affected under anaerobic conditions. The
other group of TFs, differentially affected under both aer-
obic and anaerobic conditions, must be affected by some
mechanism other than the simulated anaerobic conditions
induced by CO. For example, the other TFs may be direct
targets of CO.
The presence of CORM-3 caused a drop in expression
of many genes, notably those encoding the dipeptide
permease transporter, DppABC. In Salmonella enterica and
E. coli, S-nitrosoglutathione is internalized by the DppABC
transporter system (11,21). It has been proposed that a
periplasmic transpeptidase removes the c-glutamyl moiety
of S-nitrosoglutathione, and that the residual dipeptide,
S-nitroso-l-cysteinylglycine, is then transported inward us-
ing the Dpp-encoded dipeptide permease (7). Given our
transcriptomic data, it was plausible that this transporter
could be the route of CORM-3 uptake also. However, when
the viability of the dipeptide transport knockout strain was
tested in the presence of CORM-3, we found that this strain
was more sensitive than the wild type, and that Ru is still
able to accumulate inside the cells, suggesting that this is
not the mechanism of CORM-3 import. The increased sen-
sitivity could be due to defense against CORM-3 that re-
quires the transport of dipeptides or that this transport
system is required to repair the damage caused by the
compound. The dipeptide permease is also capable of acting
as a heme permease and is involved in endogenous peri-
plasmic heme recycling (25). It could be that this role is vital
in protecting the cell from CORM-3 via the shuttling of free
heme to form new proteins that will replace the nonfunc-
tional ones containing CO-bound heme.
It has been demonstrated several times in the literature
that thiol-containing species abolish bactericidal activity and
inhibition of respiration by transition metal-containing CO-
RMs in P. aeruginosa and E. coli (12,13,41). In agreement with
this, we have shown for the first time that cysteine and
reduced glutathione are able to abolish the inhibition
of respiration caused by exposure to CORM-3 in E. coli
membranes (Fig. 9). It has also been demonstrated that the
thiol-containing N-acetylcysteine does not interfere with CO
release from CORM-3 in the presence of dithionite (12).
However, it is possible that in the presence of membranes
alone (where dithionite is not present), the species compet-
ing with CO to bind the Ru compound and thus release CO
(28) are less competitive, and so interactions between thiol
compounds and CORM-3 cause a conformational change
that results in slower release of CO and thus an abolition of
respiratory inhibition. Indeed, it has been proposed that,
after entering blood, CORM-3 and other fac-[Ru(CO)3]
2 +
compounds react rapidly with plasma proteins, lose one
equivalent of CO as CO2, and form protein–Ru(CO)2 ad-
ducts that slowly decay with a stepwise loss of CO in
contrast to the rapid release seen in a buffer containing di-
thionite (36,37).
Together, these data highlight the importance of fully
characterizing both the compound of interest and any poten-
tial inactivated counterpart or product that may be formed, in
this case the Ru compound with labile CO removed.
Materials and Methods
Mb-CO assays
Mb-CO assays were performed using a dual-beam Rapid
Scanning Monochromator (RMS1000) spectrophotometer
(On-Line Instrument Systems, Inc.) as previouslydescribed (28).
E. coli strains and growth conditions
E. coli K12 derivative MG1655 was the strain used in all
studies. The dppB mutant was obtained from the Keio col-
lection (4,43) and transduced into MG1655 via phage P1
(24,44). Cells were grown in a glucose-limited medium
based on that of Evans et al., unless otherwise stated (15)
with the following exceptions: 2mM nitrilotriacetic acid was
used as the metal ion chelator replacing citrate; 30lg$L- 1
sodium selenite was added to the medium; and 2–20mM
glucose was used as the carbon source. For batch culture,
cells were grown at 37C and with shaking at 200 rpm in
250- or 500-ml flasks. For continuous culture, cells were
grown in an Infors Multifors bioreactor, adapted to fit a
Labfors-3 fermentor base unit. Mass flow controllers al-
lowed the correct ratio of air and pure N2 gas (aerobic
growth) or 10% O2/90% N2 and pure N2 gases (anaerobic
growth) to be mixed to produce the desired O2 input into
the chemostat.
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Measurement of O2 availability in continuous cultures
Measurement of perceived aerobiosis levels, as perceived
by cell cultures within the chemostat, was achieved as pre-
viously described (2). Acetate levels were measured using an
Enzymatic Bioanalysis kit from R-Biopharm and following
the manufacturer’s instructions.
CORM-3, iCORM-3, and CO preparation
and treatment
CORM-3 was prepared as previously described (8); a
100mM stock solution was made fresh each day by solubi-
lizing in distilled water, sparged with N2, and kept in the
dark. iCORM-3 was prepared by dissolving CORM-3 in PBS
at a final concentration of 10mM and incubating at room
temperature for *48 h, during which time the solution was
sparged periodically with N2 to remove any free CO present.
iCORM-3 was assayed for the presence of CO still capable
of release by the Mb-CO assay and was used if the resulting
Mb-CO formed was < 5% of that produced from incubation
with CORM-3.
CO-saturated solutions were made by bubbling PBS (pH
7.4) with CO gas for > 30min and used immediately. This
gave a stock concentration of CO*1mM.
CORM-3, iCORM-3, or CO-saturated solution were added
directly to continuous cultures at a steady-state OD600*0.4.
Ru analysis
Cultures were grown to log-growth phase (OD600 *0.4),
where 20ml samples were taken both before and at regular
intervals after the addition of 40 lM CORM-3 or iCORM-3.
Cells were centrifuged at 5.5 krpm for 20min in polypropyl-
ene tubes, and the pellets washed three times in 0.5% nitric
acid. Cell pellets, combined washes, and culture supernatants
were assayed in the Chemistry Department, The University of
Sheffield, for metal analysis by inductively coupled plasma
mass spectrometry (10,19).
Transcriptomic analysis
Samples were removed from chemostat cultures (two bi-
ological replicates per condition) into an ice-cold solution of
phenol/ethanol in a ratio of 1:19 to rapidly stabilize the
RNA. Total RNA was purified using an RNeasy RNA
purification kit (Qiagen) according to the manufacturer’s
instructions. cDNA was synthesized using 16lg of RNA
primed with 5lg Random Primers (Invitrogen). Reaction
mixes (30 ll) containing 0.5mM deoxyadenosine tripho-
sphate, deoxythymidine triphosphate, and deoxyguanosine
triphosphate, 0.2mM deoxycytidine triphosphate (dCTP),
and 67 lM Cy-3 or Cy-5-dCTP were incubated at 25C for
5min, and then at 50C overnight with 300U of Superscript
III Reverse Transcriptase (Invitrogen). After synthesis, cDNA
was purified using a PCR purification kit (Qiagen).
Procedures for RT-PCR were as described previously (16).
For hybridization to the microarray slides, 400 ng cDNA was
added to 25ll 2 ·Hi-RMP Hybridization Buffer and 5ll
10 ·Gene Expression Blocking Agent (Agilent Technologies)
to give a 50-ll total volume. Custom Gene Expression Mi-
croarray slides each containing 8· 15K arrayswere purchased
from Agilent Technologies. For hybridization, one 8 ·Gasket
Slide was placed inside aMicroarrayHybridization Chamber,
and the samples were loaded for eight different conditions,
followed by placement of themicroarray slide over the gasket.
After sealing the chamber, the arrays were incubated at 65C,
rotating at 10 rpm for*17 h.
After incubation, the slides were washed in Gene Expres-
sion Wash Buffer 1 for 1min, followed by washing in Gene
Expression Wash Buffer 2 for 1min. The slides were dried
and scanned in a microarray scanner (Agilent) with subse-
quent feature extraction and data analysis using GeneSpring
GX v7.3.
Modeling TF activities using TFInfer
Using the model in Sanguinetti et al. (35), we express the
log-fold change of gene expression under perturbation as the
linear combination of TF activities. The formulae and expla-
nation of the terms are included in the Supplementary Data.
The inference procedure used then gives probability dis-
tributions for the TF profiles, and TF–gene interaction
strengths based on the model and the observed gene expres-
sion data, with the means of the distributions providing point
estimates for these terms. Although the model is a simplified
representation of transcriptional regulation, it is this simplic-
ity that makes it possible to perform large-scale statistical
inference, so that one may obtain data-driven estimates of
TF activities (20).
A network of 37 TFs and 714 target genes was used for
this statistical modeling. This network consists only of the
TF–gene interactions that have been confirmed directly by
experiments such as binding of purified proteins [e.g., the
interaction of CpxR with the spy promoter (32)]. This network
is used to exclude potentially spurious TF–gene interactions
and uses only the interactions supported by very strong evi-
dence. Two included TFs, GadW and GadX, have the same
targets in this restricted representation of the transcriptional
network, so have been considered together in the analyses,
where we regard the combined contribution of GadW and
GadX under the heading GadWX.
Measuring similarity in TF activities between
two different conditions
The model above was applied independently to two data
sets from two conditions (i.e., exposed to CORMs or exposed
to iCORMs). Since the inference procedure gives a probability
distribution for TF activity, this implies a probability distri-
bution for the correlation between the activities for a given TF
in two different conditions. We calculate the mean and stan-
dard deviation of the distribution of the absolute Pearson
correlation by sampling the TF activities from the inferred
distribution and calculating the absolute Pearson correlation
of the samples (see Supplementary Data for details as to why
the absolute value of the Pearson correlation was used).
Significance testing for differences in TF activity
The TFInfer model above was modified to perform infer-
ence of two sets of TF activities simultaneously, while enfor-
cing the condition that the activity of a given TF must be the
same in both conditions. Subtracting the linear combination
of TF activities from the gene expression data then leaves
(according to the model) independent, normally distributed
residuals. Squaring the residuals and summing them gives a
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chi-squared null distribution against which we can check the
residuals from the data to check for deviation from the ex-
pected results under the null hypothesis. More details may be
found in the Supplementary Data.
In this way, we test for significant differences in TF activity
between two different conditions. This is in contrast to the
study of the Pearson correlation coefficients, which give some
measure of similarity of TF activity.
Motility assays
The swarming behavior was assessed as previously de-
scribed (31); briefly, 5ll of liquid culture in the stationary phase
was spotted onto 0.3% (w/v) LB/agar. Plates were incubated
in sealed anaerobic jars containing a normal or 50% CO gas
atmosphere. Colony diametersweremeasured after incubation
for 48h at 30C, and the values shown represent the calculated
mean– standard deviation from 16 repeats per condition.
Bactericidal assays
Cultures were grown in 20ml LB medium to an OD600
*0.5 at 37C and with shaking at 200 rpm. Samples were
removed, washed twice with PBS (pH 7.4), and diluted at
*1 · 106 colony forming units (CFU)$ml - 1. The aliquots
(5ml) were treated with the stated concentration of CORM-3
or iCORM-3 and incubated for 1 h at 37C with gentle shak-
ing. For each sample, a range of serial dilutions were plated
onto LB agar and incubated overnight for the determination
of cell viability.
Thiol and superoxide assays
For the assay of free thiols, cysteine, reduced glutathione, or
sodium hydrosulfide was incubated at room temperature for
15min with various concentrations (25–400 lM) of CORM-3,
iCORM-3, or CO-saturated solution. DTNB (0.5mM) was
subsequently added, and the solution incubated for a further
15min. The concentration of free thiols was determined by
measuring the OD412 using a Jenway spectrophotometer.
To assay for the presence of superoxide, 20 lM cytochrome
cwas added to 1mMCORM-3 in KPi (pH 7.8). The OD550 was
monitored over time to follow the appearance of reduced
cytochrome c. Superoxide dismutase (250U) was included
where indicated.
Respiration measurements
Cells were grown in LB under high aeration at 37C and
with shaking at 250 rpm until late-exponential phase. Cul-
tures were harvested and the membranes prepared as previ-
ously described (32).
E. coli membrane particles were resuspended in 2ml assay
buffer (50mM Tris-HCl, 2mM magnesium chloride, and
1mM ethylene glycol tetraacetic acid) to a final concentration
of *175 lg$ml - 1, in a stirred Perspex chamber fitted with a
Clark-type polarographic O2 electrode (OXY041A; Rank Bros
Ltd., Bottisham, CB25 9DA) held at 37C (18). The chamber
was closed, and respiration initiated by the addition of 6.25mM
nicotinamide adenine dinucleotide. The thiol compound (cys-
teine, at 400lM or reduced glutathione at 200lM) was added
to the chamber when the O2 concentration reached*165lM.
CORM-3 (400lM) was added 1min later. Data were recorded
on a chart reader (REC112; Amersham Pharmacia Biotech).
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Abbreviations Used
CO-RM¼ carbon monoxide-releasing molecule
CORM-3¼Ru(CO)3Cl(glycinate)
dCTP¼deoxycytidine triphosphate
DTNB¼ 5,5¢-dithiobis-(2-nitrobenzoic acid)
or Ellman’s reagent
iCORM-3¼ inactivated CORM-3
KPi¼potassium phosphate buffer
Mb¼myoglobin
PBS¼phosphate-buffered saline
RT-PCR¼ real time PCR
SEM¼ standard error of the mean
TF¼ transcription factor
2012 MCLEAN ET AL.
